Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation.

Chen MY, Rose CE, Qi YP, Williams JL, Yeung LF, Berry RJ, Hao L, Cannon MJ, Crider KS.

Am J Clin Nutr. 2019 May 1;109(5):1452-1461. doi: 10.1093/ajcn/nqz027.

PMID:
31005964
2.

The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy.

Cannon MJ, Block MS, Morehead LC, Knutson KL.

Immunotherapy. 2019 Feb;11(2):75-79. doi: 10.2217/imt-2018-0129. No abstract available.

3.

Regulatory T Cells in Gynecologic Cancer.

Ou Y, Cannon MJ, Nakagawa M.

MOJ Immunol. 2018;6(2):34-42. Epub 2018 Mar 16.

4.

Further clinical advancement of dendritic cell vaccination against ovarian cancer.

Morehead LC, Cannon MJ.

Ann Res Hosp. 2018 Aug;2. pii: 8. doi: 10.21037/arh.2018.08.02. Epub 2018 Aug 23. No abstract available.

5.

CMV on surfaces in homes with young children: results of PCR and viral culture testing.

Amin MM, Stowell JD, Hendley W, Garcia P, Schmid DS, Cannon MJ, Dollard SC.

BMC Infect Dis. 2018 Aug 13;18(1):391. doi: 10.1186/s12879-018-3318-z.

6.

Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening program.

Rawlinson WD, Palasanthiran P, Hall B, Al Yazidi L, Cannon MJ, Cottier C, van Zuylen WJ, Wilkinson M.

J Clin Virol. 2018 May;102:110-115. doi: 10.1016/j.jcv.2018.03.006. Epub 2018 Mar 15.

PMID:
29571077
7.

Using theory-based messages to motivate U.S. pregnant women to prevent cytomegalovirus infection: results from formative research.

Levis DM, Hillard CL, Price SM, Reed-Gross E, Bonilla E, Amin M, Stowell JD, Clark R, Johnson D, Mask K, Carpentieri C, Cannon MJ.

BMC Womens Health. 2017 Dec 14;17(1):131. doi: 10.1186/s12905-017-0482-z.

8.

IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.

Lamichhane P, Karyampudi L, Shreeder B, Krempski J, Bahr D, Daum J, Kalli KR, Goode EL, Block MS, Cannon MJ, Knutson KL.

Cancer Res. 2017 Dec 1;77(23):6667-6678. doi: 10.1158/0008-5472.CAN-17-0740. Epub 2017 Oct 9.

9.

The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer.

Allam H, Johnson BP, Zhang M, Lu Z, Cannon MJ, Abbott KL.

J Biol Chem. 2017 Sep 29;292(39):16351-16359. doi: 10.1074/jbc.M117.783936. Epub 2017 Aug 23.

10.

Trends and characteristics of fetal and neonatal mortality due to congenital anomalies, Colombia 1999-2008.

Roncancio CP, Misnaza SP, Peña IC, Prieto FE, Cannon MJ, Valencia D.

J Matern Fetal Neonatal Med. 2018 Jul;31(13):1748-1755. doi: 10.1080/14767058.2017.1326901. Epub 2017 May 22.

11.

Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review.

Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, Mulinare J, Sniezek JE, Cannon MJ, Rosenthal J.

PLoS One. 2016 Apr 11;11(4):e0151586. doi: 10.1371/journal.pone.0151586. eCollection 2016. Review.

12.

Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016.

Staples JE, Dziuban EJ, Fischer M, Cragan JD, Rasmussen SA, Cannon MJ, Frey MT, Renquist CM, Lanciotti RS, Muñoz JL, Powers AM, Honein MA, Moore CA.

MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):63-7. doi: 10.15585/mmwr.mm6503e3.

13.

Self-Reported Prevalence of Alcohol Screening Among U.S. Adults.

Denny CH, Hungerford DW, McKnight-Eily LR, Green PP, Dang EP, Cannon MJ, Cheal NE, Sniezek JE.

Am J Prev Med. 2016 Mar;50(3):380-383. doi: 10.1016/j.amepre.2015.09.016. Epub 2015 Oct 29.

14.

Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages.

Cannon MJ, Ghosh D, Gujja S.

Vaccines (Basel). 2015 May 29;3(2):448-66. doi: 10.3390/vaccines3020448. Review.

15.
16.

Seroprevalence of cytomegalovirus among children 1 to 5 years of age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012.

Lanzieri TM, Kruszon-Moran D, Amin MM, Bialek SR, Cannon MJ, Carroll MD, Dollard SC.

Clin Vaccine Immunol. 2015 Feb;22(2):245-7. doi: 10.1128/CVI.00697-14. Epub 2014 Dec 17.

17.

Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey.

Price SM, Bonilla E, Zador P, Levis DM, Kilgo CL, Cannon MJ.

BMC Womens Health. 2014 Nov 30;14:144. doi: 10.1186/s12905-014-0144-3.

18.

Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children.

Cannon MJ, Stowell JD, Clark R, Dollard PR, Johnson D, Mask K, Stover C, Wu K, Amin M, Hendley W, Guo J, Schmid DS, Dollard SC.

BMC Infect Dis. 2014 Nov 13;14:569. doi: 10.1186/s12879-014-0569-1.

19.

Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers.

Stowell JD, Mask K, Amin M, Clark R, Levis D, Hendley W, Lanzieri TM, Dollard SC, Cannon MJ.

BMC Infect Dis. 2014 Nov 12;14:568. doi: 10.1186/s12879-014-0568-2.

20.

Cytomegalovirus viral and antibody correlates in young children.

Dollard SC, Keyserling H, Radford K, Amin MM, Stowell J, Winter J, Schmid DS, Cannon MJ, Hyde TB.

BMC Res Notes. 2014 Nov 3;7:776. doi: 10.1186/1756-0500-7-776.

21.

Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer.

Mirandola L, Yu Y, Cannon MJ, Jenkins MR, Rahman RL, Nguyen DD, Grizzi F, Cobos E, Figueroa JA, Chiriva-Internati M.

Gynecol Oncol. 2014 Dec;135(3):573-9. doi: 10.1016/j.ygyno.2014.09.021. Epub 2014 Oct 6.

PMID:
25284038
22.

Prevalence and characteristics of women at risk for an alcohol-exposed pregnancy (AEP) in the United States: estimates from the National Survey of Family Growth.

Cannon MJ, Guo J, Denny CH, Green PP, Miracle H, Sniezek JE, Floyd RL.

Matern Child Health J. 2015 Apr;19(4):776-82. doi: 10.1007/s10995-014-1563-3.

23.

Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?

Cannon MJ, Griffiths PD, Aston V, Rawlinson WD.

Rev Med Virol. 2014 Sep;24(5):291-307. doi: 10.1002/rmv.1790. Epub 2014 Apr 24. Review.

24.

Ovarian tumor ascites CD14+ cells suppress dendritic cell-activated CD4+ T-cell responses through IL-10 secretion and indoleamine 2,3-dioxygenase.

Goyne HE, Stone PJ, Burnett AF, Cannon MJ.

J Immunother. 2014 Apr;37(3):163-9. doi: 10.1097/CJI.0000000000000030.

25.

Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer.

Goyne HE, Cannon MJ.

Front Immunol. 2013 Nov 18;4:382. doi: 10.3389/fimmu.2013.00382. Review.

26.

Cytomegalovirus survival and transferability and the effectiveness of common hand-washing agents against cytomegalovirus on live human hands.

Stowell JD, Forlin-Passoni D, Radford K, Bate SL, Dollard SC, Bialek SR, Cannon MJ, Schmid DS.

Appl Environ Microbiol. 2014 Jan;80(2):455-61. doi: 10.1128/AEM.03262-13. Epub 2013 Nov 1.

27.
28.

Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen.

Cannon MJ, Goyne HE, Stone PJ, Macdonald LJ, James LE, Cobos E, Chiriva-Internati M.

Cancer Immunol Immunother. 2013 May;62(5):839-49. doi: 10.1007/s00262-013-1391-0. Epub 2013 Jan 25.

29.

Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data.

Leung J, Cannon MJ, Grosse SD, Bialek SR.

BMC Infect Dis. 2012 Dec 3;12:334. doi: 10.1186/1471-2334-12-334.

30.

The case for HER2/neu as a therapeutic target for gynecologic malignancies.

Goyne HE, Cannon MJ.

Immunotherapy. 2012 Aug;4(8):781-4. doi: 10.2217/imt.12.71.

PMID:
22947006
31.

Comparison of how well conscious cats tolerate blood pressure measurement from the radial and coccygeal arteries.

Cannon MJ, Brett J.

J Feline Med Surg. 2012 Dec;14(12):906-9. doi: 10.1177/1098612X12455023. Epub 2012 Jul 24.

PMID:
22832888
32.

Progesterone effects on lymphocytes may be mediated by membrane progesterone receptors.

Ndiaye K, Poole DH, Walusimbi S, Cannon MJ, Toyokawa K, Maalouf SW, Dong J, Thomas P, Pate JL.

J Reprod Immunol. 2012 Sep;95(1-2):15-26. doi: 10.1016/j.jri.2012.04.004. Epub 2012 Jun 17.

PMID:
22709513
33.

Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus.

Cannon MJ, Westbrook K, Levis D, Schleiss MR, Thackeray R, Pass RF.

Prev Med. 2012 May;54(5):351-7. doi: 10.1016/j.ypmed.2012.03.009. Epub 2012 Mar 21.

34.

Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission.

Stowell JD, Forlin-Passoni D, Din E, Radford K, Brown D, White A, Bate SL, Dollard SC, Bialek SR, Cannon MJ, Schmid DS.

J Infect Dis. 2012 Jan 15;205(2):211-4. doi: 10.1093/infdis/jir722. Epub 2011 Nov 23.

35.

Attitudes toward newborn screening for cytomegalovirus infection.

Din ES, Brown CJ, Grosse SD, Wang C, Bialek SR, Ross DS, Cannon MJ.

Pediatrics. 2011 Dec;128(6):e1434-42. doi: 10.1542/peds.2011-1444. Epub 2011 Nov 14.

PMID:
22084323
36.

Characteristics and behaviors of mothers who have a child with fetal alcohol syndrome.

Cannon MJ, Dominique Y, O'Leary LA, Sniezek JE, Floyd RL; FASSNet Team.

Neurotoxicol Teratol. 2012 Jan-Feb;34(1):90-5. doi: 10.1016/j.ntt.2011.09.010. Epub 2011 Oct 7.

PMID:
22001355
37.

National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.

Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ.

Clin Vaccine Immunol. 2011 Nov;18(11):1895-9. doi: 10.1128/CVI.05228-11. Epub 2011 Sep 14.

38.

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend.

Kim KH, Greenfield WW, Cannon MJ, Coleman HN, Spencer HJ, Nakagawa M.

Cancer Immunol Immunother. 2012 Jan;61(1):63-70. doi: 10.1007/s00262-011-1092-5. Epub 2011 Aug 13.

39.

Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer.

Goyne H, Stone PJ, Cannon MJ.

Immunotherapy. 2011 Jul;3(7):805-7. doi: 10.2217/imt.11.71. No abstract available.

40.

Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection.

Cannon MJ, Hyde TB, Schmid DS.

Rev Med Virol. 2011 Jul;21(4):240-55. doi: 10.1002/rmv.695. Epub 2011 Jun 15. Review.

41.

Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy.

Chiriva-Internati M, Mirandola L, Yu Y, Jenkins MR, Gornati R, Bernardini G, Gioia M, Chiaramonte R, Cannon MJ, Kast WM, Cobos E.

J Immunother. 2011 Jul-Aug;34(6):490-9. doi: 10.1097/CJI.0b013e31821ca76f.

PMID:
21654522
42.

Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.

Chiriva-Internati M, Mirandola L, Kast WM, Jenkins MR, Cobos E, Cannon MJ.

Int Rev Immunol. 2011 Apr-Jun;30(2-3):71-86. doi: 10.3109/08830185.2011.561507. Review.

PMID:
21557635
43.

Prospects and challenges for immunotherapy of ovarian cancer--what can we learn from the tumor microenvironment?

Chiriva-Internati M, Cobos E, Cannon MJ.

Int Rev Immunol. 2011 Apr-Jun;30(2-3):67-70. doi: 10.3109/08830185.2011.571731.

PMID:
21557634
44.

Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer.

Chiriva-Internati M, Yu Y, Mirandola L, D'Cunha N, Hardwicke F, Cannon MJ, Cobos E, Kast WM.

Prostate. 2012 Jan;72(1):12-23. doi: 10.1002/pros.21400. Epub 2011 Apr 25.

PMID:
21520158
45.

Conjugated linoleic acid decreases prostaglandin synthesis in bovine luteal cells in vitro.

May KC, Bobe G, Mueller CJ, Cannon MJ.

Mol Reprod Dev. 2011 May;78(5):328-36. doi: 10.1002/mrd.21308. Epub 2011 Apr 8.

PMID:
21480431
46.

Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women.

Schoenfisch AL, Dollard SC, Amin M, Gardner LI, Klein RS, Mayer K, Rompalo A, Sobel JD, Cannon MJ.

J Med Microbiol. 2011 Jun;60(Pt 6):768-74. doi: 10.1099/jmm.0.027771-0. Epub 2011 Mar 10.

PMID:
21393456
47.

Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection.

Wang C, Zhang X, Bialek S, Cannon MJ.

Clin Infect Dis. 2011 Jan 15;52(2):e11-3. doi: 10.1093/cid/ciq085.

PMID:
21288834
48.

Dendritic cell vaccination against ovarian cancer--tipping the Treg/TH17 balance to therapeutic advantage?

Cannon MJ, Goyne H, Stone PJ, Chiriva-Internati M.

Expert Opin Biol Ther. 2011 Apr;11(4):441-5. doi: 10.1517/14712598.2011.554812. Epub 2011 Jan 28. Review.

49.

Efficient linking of birth certificate and newborn screening databases for laboratory investigation of congenital cytomegalovirus infection and preterm birth: Florida, 2008.

DePasquale JM, Freeman K, Amin MM, Park S, Rivers S, Hopkins R, Cannon MJ, Dy B, Dollard SC.

Matern Child Health J. 2012 Feb;16(2):486-94. doi: 10.1007/s10995-010-0740-2.

PMID:
21203810
50.

Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV.

Hyde TB, Schmid DS, Cannon MJ.

Rev Med Virol. 2010 Sep;20(5):311-26. doi: 10.1002/rmv.659. Review.

PMID:
20645278

Supplemental Content

Loading ...
Support Center